Lipoprotein (a)

Reference

Reference
Clouet-Foraison N, Marcovina SM, Guerra E, Aarsand AK, Coşkun A, Díaz-Garzón J, Fernandez-Calle P, Sandberg S, Ceriotti F, Carobene A., 2020, Clin Chem, 66, 727-36 , Analytical Performance Specifications for Lipoprotein(a), Apolipoprotein B-100, and Apolipoprotein A-I Using the Biological Variation Model in the EuBIVAS Population

Scoring

Total Score

A1,2,3,4,5,6,7,8,9,10,11,12,13,14,

Parameter Score
1. Scale A
2. Study Population A
3. Samples A
4. Measurand A
5. Pre-Analytical A
6. Replicate Analysis A
7. Steady State A
8. Outlier Analysis A
9. Normality A
10. Variance Homogeneity A
11. ANOVA A
12. CI A
13. No of Results A
14. Concentrations A
15. Total Score A1,2,3,4,5,6,7,8,9,10,11,12,13,14,
Comment A

Item Details

Parameter Score
Matrix Serum
Measurand Lipoprotein (a)
Unit mmol / L
Overall Analytical Principle Method Immunoturbidimetry
Number of Subjects
Number of Subjects included in BV estimation 25
Ethinicity Caucasian
Age Mean / Median
Age Min 21.0
Age Max 69.0
Age SD
Number of Males 38
Number of Females
State of Well Being
Healthy (excl pregnant)
Diseases
Study Duration Length 10
Study Duration Units Week
Sampling Intervals, e.g. X sample(s) per Interval Unit 1
Interval Units Week
Sampling Times Start Time:
End Time:
Number of Samples 10
Average Number of Samples Used for BV Estimation 7.8
Average Number of Replicates 1.9
Estimates of CVi 6.7
Calculated Confidence Intervals of CVi Lower: 5.97, Upper: 7.58
Estimates of CVg
Calculated Confidence Intervals of CVg Lower: , Upper:
Analytical CV 3.1
Calculated Confidence Intervals of Analytical CV Lower: 2.79, Upper: 3.49
Measurand Mean 92.7
Measurand Min
Measurand Max
Measurand SD

Coding